News | Artificial Intelligence | February 27, 2024

At ECR23, Median will unveil the latest developments for eyonis alongside its AI-powered clinical trial imaging services

At ECR23, Median will unveil the latest developments for eyonis alongside its AI-powered clinical trial imaging services

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology (ECR), being held in Vienna, Austria, February 28 – March 3, 2024.

Presentation at the AI Theater Industry Sessions/AI Lightning Talks 2 (AI exhibition, Expo X1)
February 28 at 12:30 pm CET: “Eyonis LCS: Revealing Independent Verification Results & Advancements in Clinical Validation Studies”, presented by Anne Chibois, eyonis Clinical Science Director, Median Technologies, and Benoit Huet, eyonis AI and Data Science Director, Median Technologies.

Presentation at the AI Theater Industry Sessions/AI Lightning Talks 5 (AI exhibition, Expo X1)
February 29 at 12:50 pm CET: “eyonis AI tech-based CADe/CADx device suite: unveiling independent verification results in Lung Cancer Screening & preliminary Hepatocellular carcinoma diagnosis results”, presented by Pr. Philippe Grenier, Thoracic Radiologist and Head of the Artificial Intelligence project, Foch Hospital, Saint Cloud, France and Pr. Olivier Lucidarme, Head of Radiology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.

 

Scientific poster

“Developing a novel computer-aided diagnostic technique based on deep learning and CT images for early HCC diagnosis”, O. Lucidarme, V. Paradis, C. Guettier, I. Brocheriou, J. Shen, S. Poullot , V. K. LE, V. Vilgrain , M. Lewin Zeitoun. Link available soon: EPOS™ website.

Median’s eyonis and iCRO/Imaging Lab teams will be available at booth #AI-17, AI Exhibition, Expo X1 for the duration of the industry exhibition (February 28 – March 2, 10:00 am – 5:00 pm CET).

For more information: www.mediantechnologies.com

 

Find more ECR24 conference coverage here


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
Subscribe Now